Daiichi Sankyo Reports - Industry Research
Reports Featuring Daiichi Sankyo
Global Anticoagulants Market
The Anticoagulants Market is expected to register a CAGR of 9.41% during the forecast period (2022-2027).
Japan Pharmaceutical Market
The Japan Pharmaceutical Market size is estimated at USD 88 billion in 2024, and is expected to reach USD 91.94 billion by 2029, growing at a CAGR of 0.88% during the forecast period (2024-2029).
Alopecia Treatment (Hair Loss) Market
Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues.
mRNA Vaccines and Therapeutics Market
The mRNA Vaccines and Therapeutics Market size is estimated at USD 54.70 billion in 2024, and is expected to reach USD 118.90 billion by 2029, growing at a CAGR of 16.80% during the forecast period (2024-2029).
Global Anti-hypertensive Drugs Market
The anti-hypertensive drugs market is expected to register a CAGR of 4.5% during the forecast period (2021 to 2026).
Global Monoclonal Antibody Therapeutics Market
The monoclonal antibody therapeutics market studied was anticipated to grow with a CAGR of nearly 13.2% during the forecast period.
Esomeprazole Market
The Esomeprazole Market is expected to register a CAGR of 5.2% over the forecast period.
Other Reports Covering Daiichi Sankyo
Pharmaceuticals
- Preventive Vaccines Market
- Alopecia Treatment (Hair Loss) Market
- Antibiotics Market
- Antibody-drug Conjugates Market
- Antithrombotic Drugs Market
- Asia-Pacific Acute Myeloid Leukemia Treatment Market
- Asia-Pacific Cancer Vaccines Market
- Esomeprazole Market
- Global Anti-hypertensive Drugs Market
- Global Anticoagulants Market
- Global Argatroban Market
- Global Hyperlipidemia Drugs Market
- Global Orphan Drugs Market
- Global Stroke Therapeutics Market
- Influenza Medications Market
- Intravenous Iron Drugs Market
- Iron Deficiency Anemia Therapy Market
- Japan Pharmaceutical Market
- Morphine Market
- mRNA Vaccines and Therapeutics Market
- Peptide and Anticoagulant Drugs Market
